These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé A; McNutt NS Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257 [TBL] [Abstract][Full Text] [Related]
8. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas. Shukuwa T; Katayama I; Koji T Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912 [TBL] [Abstract][Full Text] [Related]
9. Frequent downregulation of Fas (CD95) expression and function in melanoma. Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383 [TBL] [Abstract][Full Text] [Related]
10. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms. Googe PB; Flanigan KL; Miedema JR Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214 [TBL] [Abstract][Full Text] [Related]
11. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Piris A; Mihm MC; Hoang MP Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927 [TBL] [Abstract][Full Text] [Related]
13. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. Isabel Zhu Y; Fitzpatrick JE J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669 [TBL] [Abstract][Full Text] [Related]
15. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235 [TBL] [Abstract][Full Text] [Related]
16. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. Krengel S; Grotelüschen F; Bartsch S; Tronnier M J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278 [TBL] [Abstract][Full Text] [Related]
17. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]